← Back to Patent Explorer
US4320209A Expired / Lapsed US ⏱️ 0.0 years remaining

Amide nucleating agents for butene-1 polymer compositions

Assignee: Shell USA Inc
•
Filing: 1980-12-08
•
Granted: 1982-03-16
•
Expires: 2000-12-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The crystallization from the melt of an isotactic butene-1 homopolymer composition or isotactic butene-1-ethylene copolymer composition is promoted by adding a small amount of a nucleating agent selected from the group consisting of 1-naphthalene acetamide; N-stearoyl-p-aminophenol; mercapto-N-2-naphthylacetamide; malonamide; nicotinamide; isonicotinamide; benzamide; salicylamide; and anthranilamide.

Inventors

  • 👤 Ananda M. Chatterjee

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 04:25
CPC Classifications
C; C08; C08K; C08K5/00; C08K5/16; C08K5/20

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 65 words
A method for promoting crystallization from the melt of an isotactic butene-1 homopolymer or isotactic butene-1-ethylene copolymer having no more than about 15 mole percent of ethylene, which comprises adding to a composition comprising the homopolymer or copolymer about 0.02 to 5.0% by weight of a nucleating agent selected from the group consisting of 1-naphthalene acetamide; N-stearoyl-p-aminophenol; mercapto-N-2-naphthylacetamide; malonamide; nicotinamide; isonicotinamide; benzamide; salicylamide; and anthranilamide.
Claim 2
Independent Claim 65 words
A method for promoting crystallization from the melt of an isotactic butene-1 homopolymer or isotactic butene-1-ethylene copolymer having no more than about 15 mole percent of ethylene, which comprises adding to a composition comprising the homopolymer or copolymer about 0.02 to 5.0% by weight of a nucleating agent selected from the group consisting of 1-naphthalene acetamide; N-stearoyl-p-aminophenol; mercapto-N-2-naphthylacetamide; malonamide; nicotinamide; isonicotinamide; benzamide; salicylamide; and anthranilamide.
Claim 3
Dependent Claim 20 words
The method as defined in claim 1, wherein the nucleating agent is added to the composition comprising the butene-1 homopolymer.
Claim 4
Dependent Claim 28 words
The method as defined in claim 2, wherein the nucleating agent is selected from the group consisting of 1-naphthalene acetamide; N-stearoyl-p-aminophenol; mercapto-N-2-naphthylacetamide; malonamide; nicotinamide; isonicotinamide; benzamide; and anthranilamide.
Claim 5
Dependent Claim 14 words
The method as defined in claim 2, wherein the nucleating agent is 1-naphthalene acetamide.
Claim 6
Dependent Claim 20 words
The method as defined in claim 1, wherein the nucleating agent is added to the composition comprising the butene-1-ethylene copolymer.
Claim 7
Dependent Claim 21 words
The method as defined in claim 5, wherein the butene-1-ethylene copolymer contains from about 0.1 to 10 mole percent of ethylene.
Claim 8
Dependent Claim 21 words
The method as defined in claim 5, wherein the butene-1-ethylene copolymer contains from about 0.1 to 8 mole percent of ethylene.
Claim 9
Dependent Claim 23 words
The method as defined in claim 5, wherein the nucleating agent is selected from the group consisting of 1-naphthalene acetamide; benzamide; and salicylamide.
Claim 10
Dependent Claim 23 words
The method as defined in claim 7, wherein the nucleating agent is selected from the group consisting of 1-naphthalene acetamide; benzamide; and salicylamide.
Claim 11
Dependent Claim 23 words
The method as defined in claim 5, wherein the nucleating agent is selected from the group consisting of 1-naphthalene acetamide; benzamide; and salicylamide.
Claim 12
Dependent Claim 14 words
The method as defined in claim 5, wherein the nucleating agent is 1-naphthalene acetamide.
Claim 13
Dependent Claim 14 words
The method as defined in claim 7, wherein the nucleating agent is 1-naphthalene acetamide.
Claim 14
Dependent Claim 27 words
The method as defined in claim 2, wherein the nucleating agent is added to the composition in an amount of from about 0.05 to 2.5% by weight.
Claim 15
Dependent Claim 27 words
The method as defined in claim 2, wherein the nucleating agent is added to the composition in an amount of from about 0.1 to 1.0% by weight.
Claim 16
Dependent Claim 27 words
The method as defined in claim 5, wherein the nucleating agent is added to the composition in an amount of from about 0.1 to 2.5% by weight.
Claim 17
Dependent Claim 27 words
The method as defined in claim 9, wherein the nucleating agent is added to the composition in an amount of from about 0.1 to 2.5% by weight.
Claim 18
Dependent Claim 27 words
The method as defined in claim 5, wherein the nucleating agent is added to the composition in an amount of from about 0.1 to 1.0% by weight.
Claim 19
Dependent Claim 27 words
The method as defined in claim 9, wherein the nucleating agent is added to the composition in an amount of from about 0.1 to 1.0% by weight.

References Cited (Backward Citations)

US3265648A Cited
US3367926A Cited
DE1935239A1 Cited
US3756997A Cited
US3575931A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-03-15 1985-09-14 1986-03-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-03-15 1989-09-14 1990-03-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-03-15 1993-09-14 1994-03-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag